HALO Related Analyst Ratings

May 16, 2013 11:11 AM Wedbush Sees No Need to Own Halozyme (HALO)

May 14, 2013 04:25 PM Piper Jaffray Starts Halozyme Therapeutics (HALO) at Overweight

Jan 14, 2013 07:43 AM BMO Capital Upgrades Halozyme Therapeutics (HALO) to Outperform

Oct 8, 2012 01:52 PM Wedbush Analysts Sees Halozyme (HALO) Stock at $17 Per Share

Aug 16, 2012 05:27 PM Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Update From Meeting with Management

Aug 2, 2012 11:01 AM Jefferies Maintains a 'Buy' on ViroPharma (VPHM); Major Setback with SC Cinryze Using HALO Technology

Aug 2, 2012 10:55 AM Jefferies Downgrades Halozyme Therapeutics (HALO) to Underperform; FDA Orders Hold on rHuPH20 Trials

Jun 12, 2012 05:44 PM Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Apr 17, 2012 08:30 AM Jefferies Cuts Numbers on Halozyme Therapeutics (HALO)

Apr 17, 2012 08:16 AM Wedbush Reiterates an 'Outperform' on Halozyme Therapeutics (HALO); Selloff Over Done, Several Positive Catalysts Ahead

Apr 16, 2012 01:04 PM Brean Murray Carret & Co. Maintains a 'Buy' on Halozyme Therapeutics (HALO); Oversold on HyQ News - Opportunity Heading Into Rituxan Phase 3

Apr 16, 2012 12:01 PM BMO Cuts Halozyme (HALO) to Market Perform Following FDA's Request for More Info on HyQ Application

Apr 10, 2012 06:59 AM Jefferies Downgrades Halozyme Therapeutics (HALO) to Hold

Mar 8, 2012 02:49 PM Halozyme Therapeutics (HALO) Get Boost From Barclays Initiation; Shares Up Over 3%

Mar 8, 2012 07:51 AM Barclays Starts Halozyme Therapeutics (HALO) at Overweight

Nov 9, 2011 09:11 AM Wedbush Reiterates an 'Outperform' on Halozyme Therapeutics (HALO); Adding to Best Ideas List; Insulin Opportunity Under the Radar and Undervalued

Oct 18, 2011 08:31 AM JMP Securities Upgrades Halozyme Therapeutics (HALO) to Market Outperform

Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform

Aug 11, 2011 10:22 AM Roth Capital Resumes Coverage on Halozyme Therapeutics (HALO) at Buy

Apr 1, 2011 07:46 AM Stifel Nicolaus Starts Halozyme Therapeutics (HALO) at Buy

Mar 24, 2011 08:20 AM Roth Capital Upgrades Halozyme Therapeutics (HALO) to Buy

Mar 14, 2011 01:25 PM Barclays Reiterates an 'Overweight' on Halozyme Therapeutics (HALO); Upside on Pipeline Data in 2011

Oct 19, 2010 09:23 AM JMP Starts MannKind (MNKD) at Outperform, Biodel (BIOD), Halozyme (HALO) at Market Perform

Oct 12, 2010 01:54 PM Barclays Reiterates an 'Overweight' on Halozyme Therapeutics (HALO); Focusing on Late Stage Opportunities

Oct 6, 2010 12:55 PM UPDATE - Barclays Initiates Coverage on Halozyme Therapeutics (HALO) with an Overweight; Leveraging Next Gen. Biologics Delivery

Oct 6, 2010 09:35 AM Barclays Initiates Coverage on Halozyme Therapeutics (HALO) with an Overweight

Apr 8, 2010 03:23 PM Halozyme (HALO) Gets a Boost From New "Outperform" Rating at William Blair

Mar 22, 2010 08:27 AM Brean Murray Upgrades Halozyme Therapeutics (HALO) to Buy; Rethinking HALO - Thesis Works With Roche Success Alone

Oct 13, 2009 09:24 AM Wedbush Morgan Upgrades Halozyme Therapeutics (HALO) to Outperform

Oct 1, 2009 11:42 AM Merriman Curhan Ford Reiterated their Buy on Halozyme (HALO) After Data

Apr 29, 2009 07:56 AM Roth Capital Upgrades Halozyme Therapeutics (HALO) to Buy

Apr 22, 2009 11:59 AM Wedbush Morgan Initiates Coverage on Halozyme (HALO) with a Buy

Feb 26, 2009 08:04 AM Merriman Curhan Ford Initiates Coverage on Halozyme (HALO) with a Buy

Aug 11, 2008 11:15 AM Brean Murray Downgrades Halozyme Therapeutics (HALO) to Hold

Sep 11, 2007 09:33 AM Morgan Joseph Initiates Coverage on Halozyme Therapeutic (HALO) with a Sell

Jul 24, 2007 07:45 AM Oppenheimer Starts Halozyme Therapeutics (HALO) at Buy